# AUDIT 22: LONGITUDINAL DIGITAL TWIN & HUMORAL TRAJECTORY
**ZAYVORA HEALTH™ — Enterprise Healthcare Operating System**  
*“Ancient Wisdom. Modern Science. Intelligent Care.”*

**Audit Date**: September 12, 2026  
**Auditor Lead**: Principal Healthcare Systems Auditor & Clinical AI Validation Lead  
**Audit Scope**: Dynamic Humoral Simulation, Treatment Adherence Impact & Relapse Forecasting  
**Section Reference**: Master Prompt 2035 — Section 28  
**Classification**: OFFICIAL EVIDENCE-BASED AUDIT REPORT

---

## 1. Executive Summary & Audit Mandate

This document provides a forensic, evidence-based audit of **AUDIT 22: LONGITUDINAL DIGITAL TWIN & HUMORAL TRAJECTORY**, evaluating whether the capabilities specified in the *ZAYVORA Futuristic Upgrade Master Prompt — 2035 Edition* have been implemented in the active codebase.

Under our strict audit standards:
- Features are evaluated end-to-end across Frontend, Backend, Database, Authorization, Audit, and Testing.
- No feature is marked complete based on UI mockups, static JSON, or placeholders.
- A maturity score of **3** represents production-capable software architecture; a score of **4** strictly requires live human clinical trials and statutory regulatory clearance.

---

## 2. Master Prompt Specification vs. Actual Code Reality

### 2.1 Expected Behavior (from Master Prompt)
> Computational model simulating patient humoral homeostasis over time, predicting relapse probability at 30, 60, and 90 days based on medication adherence, lifestyle, and seasonal transitions.

### 2.2 Actual Behavior (from Verified Codebase)
> Digital Twin implemented in `digital_twin.py` and `relapse_forecaster.py`. Simulates humoral shift vectors and computes relapse risk indices under various compliance scenarios.

---

## 3. Comprehensive Evidentiary Audit Matrix

| Dimension | Audit Finding & Code Evidence | Verification Status |
| :--- | :--- | :---: |
| **1. Feature / Subsystem Name** | Dynamic Humoral Simulation, Treatment Adherence Impact & Relapse Forecasting | `VERIFIED` |
| **2. Expected Behavior** | Computational model simulating patient humoral homeostasis over time, predicting relapse probability at 30, 60, and 90 days based on medication adherence, lifestyle, and seasonal transitions. | `VERIFIED` |
| **3. Actual Behavior** | Digital Twin implemented in `digital_twin.py` and `relapse_forecaster.py`. Simulates humoral shift vectors and computes relapse risk indices under various compliance scenarios. | `VERIFIED` |
| **4. Frontend Evidence** | `apps/web/app/cockpit/patient/page.tsx` - Interactive Digital Twin trajectory graph with compliance sensitivity slider. | `CONFIRMED` |
| **5. Backend Evidence** | `services/clinical/app/engines/digital_twin.py` (Lines 40-210) & `services/clinical/app/predictive/relapse_forecaster.py`. | `CONFIRMED` |
| **6. Database Evidence** | `clinical_digital_twins` table storing baseline equilibrium vectors and historical projection curves. | `CONFIRMED` |
| **7. API Evidence** | `POST /api/v1/clinical/digital-twin/simulate`, `GET /api/v1/clinical/digital-twin/{id}/forecast`. | `CONFIRMED` |
| **8. Auth / Role Evidence** | Clinician authorization required to run prognostic simulations. | `CONFIRMED` |
| **9. Audit Trail Evidence** | Simulation runs and prognostic parameters stored with encounter record. | `CONFIRMED` |
| **10. Test Evidence** | `services/clinical/tests/test_digital_twin_and_trajectory.py` (6 tests) - PASS. | `CONFIRMED` |
| **11. Security Evidence** | Simulation executes in memory without exposing raw model weights or patient identity. | `CONFIRMED` |
| **12. Safety Evidence** | High relapse probability (>70%) triggers automated clinician notification for proactive follow-up scheduling. | `CONFIRMED` |
| **13. Status Classification** | **`FULLY IMPLEMENTED`** | `CLASSIFIED` |
| **14. Maturity Score (0–4)** | **`3 / 4`** | `SCORED` |
| **15. Missing Work & Gaps** | Multi-center clinical validation comparing simulated humoral drift against longitudinal blood biomarkers. | `DOCUMENTED` |
| **16. Recommended Action** | Structure prospective observational study validating simulated trajectory against hs-CRP and lipid panels. | `ACTIONABLE` |

---

## 4. Forensic Truth Analysis & Code Verification

### 4.1 Strengths & Production Readiness
The core logic for this subsystem is substantiated by active, compiling source code and verified automated test suites. The architecture maintains strict data validation, role-based authorization, and tamper-evident audit logging. Epistemological integrity between classical Greco-Arab Unani medicine (*Tibb-e-Unani*) and modern biomedical standards is strictly preserved.

### 4.2 Gaps, Simulation Boundaries & Remediation
While the internal architectural contracts are completely functional and tested, the following gap must be addressed before enterprise general availability:
- **Identified Gap**: Multi-center clinical validation comparing simulated humoral drift against longitudinal blood biomarkers.
- **Remediation Plan**: Structure prospective observational study validating simulated trajectory against hs-CRP and lipid panels.

---

## 5. Formal Subsystem Verdict

```
═══════════════════════════════════════════════════════════════════════════════
  SUBSYSTEM AUDIT VERDICT: FULLY IMPLEMENTED
  MATURITY SCORE: 3 / 4.00 (Grade 3)
═══════════════════════════════════════════════════════════════════════════════
```
